Home › Funds › RA CAPITAL MANAGEMENT, L.P. › EVMN

RA CAPITAL MANAGEMENT, L.P. position in EVMN

EVOMMUNE INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 3,494,638 shares of EVMN (EVOMMUNE INC) in its Q2 2026 13F filing — a position valued at US$46.4M, representing 0.40% of its reported portfolio and ranking #41 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed EVMN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)3.49M sh
Reported value held$46.44M
Portfolio Weight0.40%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s EVMN position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in EVMN in Q4 2025 at 3,458,770 shares (US$59.2M). The position peaked in Q1 2026 at 3,494,638 shares, worth US$80.3M. Across 3 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,494,638 shares valued at US$46.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.46M $59.21M New
Q1 2026 3.49M $80.34M Add
Q2 2026 3.49M $46.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EVMN and 13F data

EVMN (EVOMMUNE INC) is a Health Care company. 116 other funds we track also report a position in EVMN — the largest reported positions include EQT Fund Management S.a r.l. (US$70.3M), SymBiosis Capital Partners, LLC (US$29.4M), Pivotal bioVenture Partners Investment Advisor LLC (US$25.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EVMN

All EVMN fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held EVMN?

RA CAPITAL MANAGEMENT, L.P. has disclosed EVMN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in EVMN?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 3.49M shares of EVMN (EVOMMUNE INC), valued at $46.44M, representing 0.40% of its reported portfolio and ranking #41.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling EVMN?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in EVMN. The position peaked in Q1 2026 at 3.49M shares.

Which other funds hold EVMN?

Other major institutional holders of EVMN include EQT Fund Management S.a r.l., SymBiosis Capital Partners, LLC, Pivotal bioVenture Partners Investment Advisor LLC, among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.